Protein splicing: A versatile tool for drug discovery

被引:33
作者
Cheriyan, Manoj [1 ]
Perler, Francine B. [1 ]
机构
[1] New England Biolabs Inc, Ipswich, MA 01938 USA
关键词
Intein; Conditional protein splicing; Split-intein; Gene therapy; SICLOPPS; Cyclic peptides; Antimicrobial drug target; Trans-splicing; EPL; NATIVE CHEMICAL LIGATION; SPLIT RENILLA LUCIFERASE; SMALL-MOLECULE; MAMMALIAN-CELLS; IN-VITRO; ADENOSINE-TRIPHOSPHATASE; ENDOPLASMIC-RETICULUM; NUCLEAR TRANSPORT; GENETIC SELECTION; CYCLIC-PEPTIDES;
D O I
10.1016/j.addr.2009.04.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The judicious application of intein technologies to biological problems has resulted in powerful tools for biomedical research. Inteins are intervening sequences that excise themselves from precursor proteins and ligate the surrounding sequences. Variations of intein chemistry have been used to create tagless protein purification strategies, specifically label expressed proteins for biochemical assays, design biosensors, produce microarrays, and synthesize cyclic peptide libraries for inhibitor studies. Moreover, recent advances in small molecule triggered protein splicing allow for tunable post-translational control of protein function in vivo. Inteins are now positioned as an essential tool to study the mechanism of disease progression and validate drug candidates. Yet these tiny proteins have more tricks to play. Recent progress in gene therapy and drug targeting suggest a bright future where split inteins mediate in vivo reconstruction of large therapeutic proteins and target drugs to a specified site of action. Inteins are rapidly becoming valuable tools for drug discovery and drug delivery. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:899 / 907
页数:9
相关论文
共 95 条
[1]  
Adam E, 2002, J MOL MICROB BIOTECH, V4, P479
[2]   Intein-mediated synthesis of geranylgeranylated Rab7 protein in vitro [J].
Alexandrov, K ;
Heinemann, I ;
Durek, T ;
Sidorovitch, V ;
Goody, RS ;
Waldmann, H .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (20) :5648-5649
[3]  
Ando T, 2007, CHEM COMMUN, P4995, DOI 10.1039/b712843f
[4]   Novel Split Intein for trans-Splicing Synthetic Peptide onto C Terminus of Protein [J].
Appleby, Julia H. ;
Zhou, Kaisong ;
Volkmann, Gerrit ;
Liu, Xiang-Qin .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (10) :6194-6199
[5]   Incorporation of spin-labelled amino acids into proteins [J].
Becker, CFW ;
Lausecker, K ;
Balog, M ;
Kálai, T ;
Hideg, K ;
Steinhoff, HJ ;
Engelhard, M .
MAGNETIC RESONANCE IN CHEMISTRY, 2005, 43 (43) :S34-S39
[6]   Probing the role of axial methionine in the blue copper center of azurin with unnatural amino acids [J].
Berry, SM ;
Ralle, M ;
Low, DW ;
Blackburn, NJ ;
Lu, Y .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (29) :8760-8768
[7]   An engineered azurin variant containing a selenocysteine copper ligand [J].
Berry, SM ;
Gieselman, MD ;
Nilges, MJ ;
van der Donk, WA ;
Lu, Y .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (10) :2084-2085
[8]   Design of an intein that can be inhibited with a small molecule ligand [J].
Brenzel, S ;
Mootz, HD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (12) :4176-4177
[9]   Directed evolution of ligand dependence: Small-molecule-activated protein splicing [J].
Buskirk, AR ;
Ong, YC ;
Gartner, ZJ ;
Liu, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (29) :10505-10510
[10]   The distribution and evolutionary history of the PRP8 intein [J].
Butler, Margaret I. ;
Gray, Jeremy ;
Goodwin, Timothy J. D. ;
Poulter, Russell T. M. .
BMC EVOLUTIONARY BIOLOGY, 2006, 6 (1)